Syntheia Announces Private Placement

Executive Summary

• Syntheia Corp. announced a non‑brokered private placement of up to 17,500,000 units at $0.12 per unit, targeting gross proceeds of up to $2.1 million.
• Each unit consists of one common share and half of a transferable warrant exercisable at $0.20 for 36 months; finder warrants and an 8% cash commission are also part of the deal.
• Proceeds will be used for general working capital, and the offering is expected to close on or about February 20, 2026, subject to regulatory approvals.

Key Details

• Units Offered: Up to 17,500,000 units at $0.12 per unit.
• Gross Proceeds Target: Up to $2,100,000.
• Unit Composition: 1 common share + ½ transferable warrant (each whole warrant = right to purchase one common share at $0.20).
• Warrant Terms: Exercisable for 36 months from closing date; accelerated expiry possible if CSE price > $0.40 for 20 consecutive trading days (notice‑accelerated expiry 30 days after notice).
• Finder Compensation: 8.0% cash commission on gross proceeds plus finder warrants equal to up to 8.0% of units sold. Finder warrants allow purchase of common shares at the offering price for 24 months.
• Use of Proceeds: General working capital purposes.
• Closing Date: Expected on or about February 20, 2026, subject to receipt of all required regulatory and CSE approvals.
• Exemptions Utilized: Listed Issuer Financing Exemption under NI 45‑106 (Part 5A) for Canadian provinces (excluding Quebec); U.S. private placement exemption under the Securities Act; other jurisdictions as applicable.
• Regulatory Conditions: Offering subject to compliance with NI 45‑106, CSE approval, and any other required regulatory approvals.

Notable Quotes

(No executive quotes were provided in the release.)